Canada’s Drug Agency | Drugs, Health Technologies and Systems.
Canada’s Drug Agency | Drugs, Health Technologies and Systems.

Rapid Point-of-Care Antigen Testing for SARS-CoV-2 Infection

Details

Files
Project Line:
Health Technology Review
Project Sub Line:
Health Technology Update
Project Number:
EN0025-000

This newsletter explores recent developments in testing for COVID-19. Testing for COVID-19 infection is important to stopping spread of the virus. There is also a need for tests that can quickly provide results. Evidence related to rapid point-of-care antigen testing — such as current practice, availability in Canada, cost, and safety — are summarized in this publication.

Files

Rapid Point-of-Care Antigen Testing for SARS-CoV-2 Infection View PDF
Last Updated : October 20, 2020